HealthEquity (NASDAQ:HQY) Research Coverage Started at The Goldman Sachs Group

The Goldman Sachs Group initiated coverage on shares of HealthEquity (NASDAQ:HQY) in a research note issued to investors on Friday morning, Marketbeat reports. The brokerage issued a neutral rating and a $108.00 target price on the stock.

A number of other research analysts have also weighed in on HQY. Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Bank of America boosted their price objective on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. BTIG Research raised their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday. Barrington Research reiterated an “outperform” rating and set a $105.00 price target on shares of HealthEquity in a research report on Friday, September 20th. Finally, JMP Securities restated a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $107.23.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $98.98 on Friday. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. The stock has a fifty day simple moving average of $85.02 and a two-hundred day simple moving average of $81.09. HealthEquity has a 1-year low of $62.10 and a 1-year high of $101.17. The firm has a market cap of $8.64 billion, a price-to-earnings ratio of 82.48, a price-to-earnings-growth ratio of 1.55 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.16. The company had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. Analysts anticipate that HealthEquity will post 2.27 earnings per share for the current year.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now directly owns 54,719 shares of the company’s stock, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the sale, the director now owns 4,823 shares of the company’s stock, valued at approximately $387,093.98. The trade was a 20.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 10,536 shares of company stock worth $884,517. Corporate insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

A number of large investors have recently added to or reduced their stakes in the business. International Assets Investment Management LLC bought a new position in shares of HealthEquity during the second quarter valued at about $35,000. Paladin Wealth LLC bought a new position in HealthEquity during the 3rd quarter worth approximately $39,000. GAMMA Investing LLC increased its stake in HealthEquity by 114.8% in the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after purchasing an additional 318 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in HealthEquity in the second quarter valued at approximately $73,000. Finally, Quarry LP lifted its position in HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after purchasing an additional 1,089 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.